PAR-19-282 - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research NOT-CA-22-037 NCI , NHLBI , NIA , NIDA , NIMH , NINR , OBSSR Jan 27, 2022 Mar 9, 2024 R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-22-022 ODP , NIDCR , NCI , NIEHS , NIDA Dec 9, 2021 May 9, 2023 R01, R61/R33, R21, 333, R03
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects NOT-OD-22-023 ODP , NCI , NIDA , NIMHD , NIDCR Dec 8, 2021 May 9, 2024 R21, R01, 333, R34, R03, R61/R33
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders NOT-DA-20-021 NIDA Mar 25, 2020 Sep 8, 2023 R01, R03, R21, K99/R00, R61/R33

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster